logo
Trader Joe's Issues Massive Sparkling Water Recall Across 12 States

Trader Joe's Issues Massive Sparkling Water Recall Across 12 States

Yahoo17-03-2025

Trader Joe's has issued a major recall affecting tens of thousands of Gerolsteiner Sparkling Natural Mineral Water bottles across 12 states due to potential glass bottle defects. Here's everything you need to know about this massive recall.
On March 12th, Trader Joe's issued a recall for more than 60,000 bottles of Gerolsteiner Sparkling Natural Mineral Water due to a potential safety risk. The recall follows a notification from the product's supplier, Germany-based Gerolsteiner, warning that certain lot codes of the glass bottles could be cracked or damaged, posing a laceration hazard.
In a statement, Trader Joe's explained, 'The issue was identified through research related to bottle breakage during production and potentially affects 1 percent of bottles in the lot codes,' which are detailed below.
Consumers can check if they have the recalled Gerolsteiner Sparkling Natural Mineral Water by looking for the affected lot codes, printed on the lower part of the white, blue, and red label:
2024/28/11 24 2027/19/12
2024/271/11 24 2027/18/12
The recalled sparkling water was sold in 750-milliliter glass bottles, available individually or in cases of 15 bottles. It was distributed in 12 states—Alabama, Arkansas, Colorado, Florida, Georgia, Kansas, Louisiana, New Mexico, Oklahoma, South Carolina, Tennessee, and Texas—between December 27th, 2024, and January 28th, 2025.
Customers who purchased these bottles should stop using them immediately. Trader Joe's advises careful disposal and offers a full refund at any store location. For further inquiries, contact Trader Joe's Customer Relations at (626) 599-3817 or via the retailer's online contact form.
Fortunately, as of now, no customer injuries have been reported in connection with the damaged bottles.
In recent years, several bottled water recalls have been issued due to serious safety concerns, ranging from chemical contamination to bacterial risks. Here are some of the most significant cases:
Peñafiel Mineral Spring Water Recall (2019): Keurig Dr Pepper voluntarily recalled all unflavored Peñafiel Mineral Spring Water after testing detected arsenic levels exceeding the FDA's allowable limit of 10 parts per billion. Although no immediate injuries were reported, long-term exposure to arsenic is linked to increased risks of cancer, cardiovascular disease, and neurological issues.
Real Water Recall (2021): Real Water issued a nationwide recall after its alkalized bottled water was linked to a hepatitis outbreak that caused acute liver failure in multiple consumers. The FDA and CDC launched an investigation following reports of severe non-viral hepatitis, particularly among children, leading to several hospitalizations. The outbreak was traced to Real Water's Las Vegas-based facility, prompting the company to shut down operations permanently. Numerous lawsuits were filed by affected consumers, underscoring the dangers of inadequately treated bottled water.
Fiji Water Recall (2024): Nearly 2 million plastic bottles of Fiji Water were recalled after FDA testing detected elevated levels of manganese and potentially harmful bacteria strains. While no illnesses were immediately reported, the contamination posed potential health risks, particularly for individuals with weakened immune systems.
Source:
Read the original article on GEEKSPIN. Affiliate links on GEEKSPIN may earn us and our partners a commission.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

European Market Insights: genOway Société anonyme And 2 Promising Penny Stocks
European Market Insights: genOway Société anonyme And 2 Promising Penny Stocks

Yahoo

timean hour ago

  • Yahoo

European Market Insights: genOway Société anonyme And 2 Promising Penny Stocks

The European market has shown resilience with the pan-European STOXX Europe 600 Index rising by 0.90%, buoyed by a slowdown in inflation and easing monetary policy from the European Central Bank. As investors navigate these evolving conditions, penny stocks—often representing smaller or newer companies—continue to capture interest for their potential growth at accessible price points. Despite being an outdated term, penny stocks remain relevant as they can offer opportunities for those seeking to invest in financially strong companies with promising prospects. Name Share Price Market Cap Financial Health Rating Mistral Iberia Real Estate SOCIMI (BME:YMIB) €1.01 €22M ★★★★★☆ KebNi (OM:KEBNI B) SEK1.996 SEK541.22M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.61 SEK270.7M ★★★★★★ Cellularline (BIT:CELL) €2.95 €62.22M ★★★★★☆ Fondia Oyj (HLSE:FONDIA) €4.78 €17.87M ★★★★★★ Abak (WSE:ABK) PLN4.00 PLN10.78M ★★★★★★ Bredband2 i Skandinavien (OM:BRE2) SEK2.38 SEK2.28B ★★★★☆☆ Hifab Group (OM:HIFA B) SEK3.62 SEK220.24M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.175 €300.29M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.936 €31.34M ★★★★★★ Click here to see the full list of 447 stocks from our European Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: genOway Société anonyme is a biotechnology company that develops and commercializes custom genetically modified mouse, rat, and cell line models globally, with a market cap of €31.44 million. Operations: The company's revenue is derived entirely from its biotechnology segment, amounting to €27.53 million. Market Cap: €31.44M genOway Société anonyme, with a market cap of €31.44 million, has shown consistent revenue growth, reporting €22.06 million in sales for 2024, up from €20.05 million the previous year. The company maintains strong financial health with short-term assets exceeding both its short and long-term liabilities and a satisfactory net debt to equity ratio of 3.4%. Despite not outperforming the biotech industry in earnings growth last year, genOway's profitability has improved over five years at an impressive annual rate of 67.1%, supported by high-quality earnings and stable weekly volatility at 6%. Click here and access our complete financial health analysis report to understand the dynamics of genOway Société anonyme. Learn about genOway Société anonyme's historical performance here. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Kudelski SA, with a market cap of CHF67.34 million, offers digital access and security solutions for digital television and interactive applications across Switzerland, the United States, France, Germany, Austria, and other international markets. Operations: The company's revenue is primarily derived from three segments: Digital TV ($227.83 million), Cybersecurity ($108.47 million), and Internet of Things ($47.43 million). Market Cap: CHF67.34M Kudelski SA, with a market cap of CHF67.34 million, operates in digital access and security solutions across multiple markets. Despite being unprofitable with increasing losses over the past five years, it holds strong financials with short-term assets exceeding liabilities and more cash than debt. The seasoned management team and board bring stability, while recent partnerships in IoT and AI sectors highlight strategic growth efforts. Notably, Kudelski's collaboration with Stotz Equipment enhances asset visibility solutions without subscription fees, potentially driving future revenue streams within diverse industries like agriculture and construction. The stock trades significantly below estimated fair value compared to peers. Navigate through the intricacies of Kudelski with our comprehensive balance sheet health report here. Evaluate Kudelski's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: PCC Exol S.A. manufactures and distributes surfactants both in Poland and internationally, with a market cap of PLN452.76 million. Operations: The company's revenue is primarily derived from its Specialty Chemicals segment, totaling PLN996.33 million. Market Cap: PLN452.76M PCC Exol S.A., with a market cap of PLN452.76 million, shows promising financials as its short-term assets exceed both long-term and short-term liabilities. The company's earnings growth of 23.1% over the past year surpasses its five-year average and outpaces the broader Chemicals industry growth rate. However, while interest payments are well covered by EBIT, operating cash flow covers only 17% of debt, indicating potential liquidity concerns. Despite a high net debt to equity ratio of 54.1%, PCC Exol maintains high-quality earnings with no significant shareholder dilution recently and offers a price-to-earnings ratio below the Polish market average. Get an in-depth perspective on PCC Exol's performance by reading our balance sheet health report here. Explore historical data to track PCC Exol's performance over time in our past results report. Take a closer look at our European Penny Stocks list of 447 companies by clicking here. Interested In Other Possibilities? These 18 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:ALGEN SWX:KUD and WSE:PCX. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio

Bayern Munich acquire Tom Bischof in time for Club World Cup
Bayern Munich acquire Tom Bischof in time for Club World Cup

Yahoo

timean hour ago

  • Yahoo

Bayern Munich acquire Tom Bischof in time for Club World Cup

Kicker reports that FC Bayern Munich have reached an agreement with Hoffenheim for the early procurement of midfielder Tom Bischof. The Bundesliga Champions thus secure Bischof's services in time for the coming Club World Cup. Hoffenheim shall receive a €300,000 base-transfer-fee as part of the del. Bonuses are also included. Bayern have already paid Bayer Leverkusen a special fee to acquire defender Jonathan Tah in time for the coming tournament. Bischof, like Tah, was picked up by Bayern on a free transfer. Both players were nevertheless not technically property of the German record champions until June 30th, 2025, when their contracts with their current Bundesliga clubs expired. Advertisement The deal that will send Bischof to the German giants early was first revealed by RTL commentator Lothar Matthäus during last night's Germany-France Nations League fixture. Bischof made his German national team debut as a substitute in last night's 0-2 loss in Stuttgart. Kicker later confirmed arrangement and the precise amount. GGFN | Peter Weis

European Stocks That Might Be Trading Below Their Estimated Value
European Stocks That Might Be Trading Below Their Estimated Value

Yahoo

timean hour ago

  • Yahoo

European Stocks That Might Be Trading Below Their Estimated Value

As the European markets experience a positive shift with major stock indexes rising on the back of slowed inflation and eased monetary policy by the European Central Bank, investors are increasingly eyeing opportunities that may be trading below their estimated value. In such an environment, identifying stocks that are potentially undervalued can provide investors with promising prospects to explore, especially when economic indicators suggest stability and growth in key regions. Name Current Price Fair Value (Est) Discount (Est) VIGO Photonics (WSE:VGO) PLN530.00 PLN1023.60 48.2% Trøndelag Sparebank (OB:TRSB) NOK113.90 NOK223.35 49% Sparebank 68° Nord (OB:SB68) NOK179.38 NOK357.63 49.8% Lectra (ENXTPA:LSS) €24.10 €46.69 48.4% doValue (BIT:DOV) €2.27 €4.46 49.1% DigiTouch (BIT:DGT) €1.865 €3.66 49% Airbus (ENXTPA:AIR) €165.34 €325.34 49.2% adidas (XTRA:ADS) €211.40 €415.23 49.1% Absolent Air Care Group (OM:ABSO) SEK211.00 SEK416.55 49.3% ABO Energy GmbH KGaA (XTRA:AB9) €37.70 €73.01 48.4% Click here to see the full list of 184 stocks from our Undervalued European Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Overview: CVC Capital Partners plc is a private equity and venture capital firm that focuses on middle market secondaries, infrastructure and credit, management buyouts, leveraged buyouts, growth equity, mature investments, recapitalizations, strip sales and spinouts with a market cap of €17.42 billion. Operations: The firm's revenue segments include €135.64 million from credit, €94.99 million from secondaries, €89.56 million from infrastructure, and €861.04 million from private equity. Estimated Discount To Fair Value: 28.9% CVC Capital Partners is trading at €16.39, significantly below its estimated fair value of €23.06, presenting a potential opportunity for investors focusing on undervalued stocks based on cash flows. Despite recent volatility and high debt levels, CVC's earnings are forecast to grow significantly at 31% annually over the next three years, outpacing the Dutch market's growth rate. Recent M&A interest in BASF SE's coatings business indicates active strategic positioning which could impact future cash flows positively. The growth report we've compiled suggests that CVC Capital Partners' future prospects could be on the up. Delve into the full analysis health report here for a deeper understanding of CVC Capital Partners. Overview: Comet Holding AG, with a market cap of CHF1.79 billion, offers X-ray and radio frequency power technology solutions across Europe, North America, Asia, and other international markets through its subsidiaries. Operations: The company's revenue is derived from its X-Ray Systems (CHF115.89 million), Industrial X-Ray Modules (CHF94.57 million), and Plasma Control Technologies (CHF247.39 million) segments. Estimated Discount To Fair Value: 36% Comet Holding AG, trading at CHF 231, is significantly undervalued with a fair value estimate of CHF 361.15. The company's earnings grew by 128.2% last year and are forecast to grow at an impressive rate of 37.3% annually, outpacing the Swiss market's growth rate. Recent sales results show a robust increase to CHF 111.2 million for Q1 2025, up from CHF 80.9 million in Q1/24, reinforcing its strong cash flow position despite recent board changes. Our growth report here indicates Comet Holding may be poised for an improving outlook. Dive into the specifics of Comet Holding here with our thorough financial health report. Overview: Rosenbauer International AG provides systems for preventive firefighting and disaster protection technology globally, with a market cap of €418.20 million. Operations: The company's revenue is primarily derived from Europe (€675.84 million), followed by the Americas (€362.28 million), Asia-Pacific (€150.11 million), and the Middle East & Africa (€125.11 million), with additional income from Preventive Fire Protection systems (€30.67 million). Estimated Discount To Fair Value: 25.9% Rosenbauer International AG is trading at €41, notably below its estimated fair value of €55.33, suggesting it is significantly undervalued based on cash flows. Recent earnings reports show a strong turnaround from a net loss to a net income of €26.96 million in 2024, with expected annual earnings growth of 22.9%, surpassing the Austrian market's rate. However, interest payments remain inadequately covered by earnings despite revenue growth projections outpacing the local market. Our expertly prepared growth report on Rosenbauer International implies its future financial outlook may be stronger than recent results. Get an in-depth perspective on Rosenbauer International's balance sheet by reading our health report here. Discover the full array of 184 Undervalued European Stocks Based On Cash Flows right here. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTAM:CVC SWX:COTN and WBAG:ROS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store